David Arkowitz

Affiliations

  • Director at Ibio Inc. (IBIO), 2025-01-13
  • at Kineta Inc. (KA), 2024-09-05
  • Chief Financial Officer at Seres Therapeutics Inc. (MCRB), 2024-02-17
  • Director at F-Star Therapeutics Inc. (FSTX), 2023-03-09
  • Chief Financial Officer at Flexion Therapeutics Inc (FLXN), 2021-05-12
  • Evp, Cfo, Cbo at Amag Pharmaceuticals Inc. (AMAG), 2011-06-01
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IBIO $2.72 18,382 $49,999.04 18,382 2025-01-10 Filing
FLXN $11.05 2,500 $27,626.75 89,424 2019-05-31 Filing
FLXN $11.99 4,000 $47,960.00 86,924 2019-05-13 Filing
FLXN $16.56 4,000 $66,221.60 48,250 2018-11-09 Filing
FLXN $23.42 4,000 $93,680.00 44,250 2018-08-09 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MCRB $1.08 3,939 $4,254.12 182,442 2024-02-16 Filing
MCRB $1.35 4,066 $5,489.10 175,756 2023-10-30 Filing
FLXN $7.23 2,229 $16,115.67 220,719 2021-05-10 Filing
FLXN $11.13 6,073 $67,592.49 151,048 2021-01-05 Filing
FLXN $10.88 2,413 $26,253.44 117,068 2020-05-07 Filing